Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

18.10.2021

1 Ann Intern Med
2 BMJ
1 Clin Infect Dis
1 Indian Pediatr
1 J Infect
3 J Infect Dis
1 J Virol
7 JAMA
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nat Immunol
2 Pediatrics
2 PLoS Comput Biol
5 PLoS One
1 Proc Natl Acad Sci U S A
2 Science
18 Vaccine



    Ann Intern Med

  1. MELMED GY, Botwin GJ, Sobhani K, Li D, et al
    Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2483.
    >> Share


    BMJ

  2. PATERLINI M
    Covid-19: Sweden, Norway, and Finland suspend use of Moderna vaccine in young people "as a precaution".
    BMJ. 2021;375:n2477.
    >> Share

  3. MAHASE E
    Covid-19: Trial participants are offered approved vaccines so they can travel abroad.
    BMJ. 2021;375:n2474.
    >> Share


    Clin Infect Dis

  4. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    >> Share


    Indian Pediatr

  5. KUMAR RK
    Home Vaccination - The way forward in a Pandemic.
    Indian Pediatr. 2021;58:998.
    >> Share


    J Infect

  6. ANIS E, Haas EJ, Indenbaum V, Singer SR, et al
    A prolonged, nationwide measles outbreak despite very high vaccination coverage in Israel, 2018-19.
    J Infect. 2021 Oct 6. pii: S0163-4453(21)00497.
    >> Share


    J Infect Dis

  7. DODD RY, Notari EP, Brodsky JP, Foster GA, et al
    Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 - June 2021.
    J Infect Dis. 2021 Oct 9. pii: 6385747. doi: 10.1093.
    >> Share

  8. DILLER JR, Carter MH, Kanai Y, Sanchez SV, et al
    Monoreassortant rotaviruses of multiple G types are differentially neutralized by sera from infants vaccinated with ROTARIX(R) and RotaTeq(R).
    J Infect Dis. 2021 Oct 10. pii: 6386353. doi: 10.1093.
    >> Share

  9. PETERSON JT, Zareba AM, Fitz-Patrick D, Essink BJ, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Co-Administered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
    J Infect Dis. 2021 Oct 12. pii: 6391485. doi: 10.1093.
    >> Share


    J Virol

  10. DONG H, Lu Y, Zhang Y, Mu S, et al
    A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
    J Virol. 2021;95:e0017721.
    >> Share


    JAMA

  11. KRONMAL SL
    Shots in Arms.
    JAMA. 2021;326:1151-1152.
    >> Share

  12. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.
    >> Share

  13. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    >> Share

  14. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    >> Share

  15. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.
    >> Share

  16. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    >> Share

  17. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
    >> Share


    MMWR Morb Mortal Wkly Rep

  18. HILL HA, Yankey D, Elam-Evans LD, Singleton JA, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1435-1440.
    >> Share


    N Engl J Med

  19. NOLAN T, Fortanier AC, Leav B, Poder A, et al
    Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
    N Engl J Med. 2021;385:1485-1495.
    >> Share

  20. COLLIER AY, Yu J, McMahan K, Liu J, et al
    Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.
    N Engl J Med. 2021 Oct 15. doi: 10.1056/NEJMc2115596.
    >> Share


    Nat Immunol

  21. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    >> Share


    Pediatrics

  22. STEFFENS MS, Dunn AG, Marques MD, Danchin M, et al
    Addressing Myths and Vaccine Hesitancy: A Randomized Trial.
    Pediatrics. 2021 Oct 11. pii: peds.2020-049304. doi: 10.1542/peds.2020-049304.
    >> Share


  23. Recommendations for Prevention and Control of Influenza in Children, 2021-2022.
    Pediatrics. 2021 Sep 7. pii: peds.2021-053745. doi: 10.1542/peds.2021-053745.
    >> Share


    PLoS Comput Biol

  24. ZARNITSYNA VI, Akondy RS, Ahmed H, McGuire DJ, et al
    Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination.
    PLoS Comput Biol. 2021;17:e1009468.
    >> Share

  25. GONCALVES BP, Procter SR, Clifford S, Koukounari A, et al
    Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
    PLoS Comput Biol. 2021;17:e1009001.
    >> Share


    PLoS One

  26. WHELAN J, Marshall H, Sullivan TR
    Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.
    PLoS One. 2021;16:e0254330.
    >> Share

  27. ZAKHOUR R, Tamim H, Faytrouni F, Khoury J, et al
    Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country.
    PLoS One. 2021;16:e0258258.
    >> Share

  28. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    >> Share

  29. NAVASCUES M, Budroni C, Guryanova Y
    Disease control as an optimization problem.
    PLoS One. 2021;16:e0257958.
    >> Share

  30. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    >> Share


    Proc Natl Acad Sci U S A

  31. GARCIA-SASTRE A
    Genomics serology to inform therapies and vaccines for arthritogenic alphaviruses.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


    Science

  32. VOGEL G
    WHO gives first malaria vaccine the green light.
    Science. 2021;374:245-246.
    >> Share

  33. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
    mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
    Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
    >> Share


    Vaccine

  34. VANDERMEULEN C, Leroux-Roels I, Vandeleur J, Staniscia T, et al
    A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01283.
    >> Share

  35. VERBERK JDM, van Dongen JAP, van de Kassteele J, Andrews NJ, et al
    Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01262.
    >> Share

  36. LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
    A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
    >> Share

  37. PARK WJ, Yoon YK, Kim Y, Park JS, et al
    Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to DeltaVP8* protein from rotavirus.
    Vaccine. 2021 Oct 9. pii: S0264-410X(21)01282.
    >> Share

  38. HART P, Farrar J
    The influenza vaccines roadmap - A better future through improved influenza vaccines.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01286.
    >> Share

  39. ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
    Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
    >> Share

  40. ALI SAHRAIAN M, Ghadiri F, Azimi A, Naser Moghadasi A, et al
    Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV.
    Vaccine. 2021;39:6347-6350.
    >> Share

  41. VADREVU KM, Raju D, Rani S, Reddy S, et al
    Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV(R)) vaccine up to 7years following primary vaccination of children<2years of age with, or without, a booster vaccination.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)00966.
    >> Share

  42. BRUCE YU Y, Taraban MB, Briggs KT
    All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01280.
    >> Share

  43. FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
    Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
    >> Share

  44. FU LY, Torres R, Caleb S, Cheng YI, et al
    Vaccination coverage among young homeless children compared to US national immunization survey data.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01288.
    >> Share

  45. MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
    Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
    >> Share

  46. MOLODECKY NA, Jafari H, Safdar RM, Ahmed JA, et al
    Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01228.
    >> Share

  47. CORCORAN KE, Scheitle CP, DiGregorio BD
    Christian nationalism and COVID-19 vaccine hesitancy and uptake.
    Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
    >> Share

  48. MULLER-PEBODY B, Sinnathamby MA, Warburton F, Rooney G, et al
    Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)01284.
    >> Share

  49. GIERSING B, Shah N, Kristensen D, Amorij JP, et al
    Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)00996.
    >> Share

  50. BRYDEN GM, Rockloff M, Browne M, Unsworth C, et al
    Effect of contamination and purity priming on attitudes to vaccination and other health interventions: A randomised controlled experiment.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01278.
    >> Share

  51. DRAPER M, Stergiopoulos S
    Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01223.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016